The NCRI Brain Group has three subgroups that develop research in areas of strategic need.


The Glioma Subgroup, chaired by Dr Sara Erridge, develops research into a type of tumour that begins in glial cells and occurs in the brain and spinal cord.


Sara Erridge, Consultant Clinical Oncologist, Western General Hospital (subgroup chair)

Thomas Booth, Consultant Diagnostic & Interventional Neuroradiologist, King’s College Hospital NHS Foundation Trust

Paul Brennan, Neurosurgeon, University of Edinburgh

Laura Clifton-Hadley, Trials Group Leader, University College London (UCL)

Sarah Jefferies, Addenbrooke’s Hospital NHS Foundation Trust

Juanita Lopez, Consultant Medical Oncologist, Royal Marsden NHS Foundation Trust

Ryan Mathew, Leeds Teaching Hospitals NHS Trust – Leeds General Infirmary

Dusan Milanovic, Clinical Oncologist, University Hospitals of Leicester NHS Trust

Paul Miller, NIHR Clinical Lecturer in Medical Oncology, University of Oxford

James Powell, Consultant Clinical Oncologist, Velindre Cancer Centre

Faye Robertson, CRUK Clinical Research Fellow, University of Edinburgh

Stuart Smith, Clinical Associate Professor of Neurosurgery, University of Nottingham

Gerard Thompson, Senior Clinical Lecturer in Neuroradiology, University of Edinburgh

Igor Vivanco, Team Leader in Molecular Addictions, Institute of Cancer Research (ICR)

Matt Williams, Consultant Clinical Oncologist, Imperial College London

The Meningioma, Metastases & Other Tumours Subgroup, chaired by Professor Oliver Hanemann, develops research into other types of brain tumour including meningioma and brain tumours that have metastasised.


Oliver Hanemann, Neurologist, University of Plymouth (subgroup chair)

Usama Ali, NCRI Consumer Forum member

Richard Baird, Academic Consultant in Breast Cancer Theraputics and Honorary Consultant Medical Oncologist, University of Cambridge

Juliet Brock, Consultant Clinical Oncologist, Brighton and Sussex University Hospitals NHS Trust

Michael Jenkinson, Clinical Senior Lecturer and Honorary Consultant Neurosurgeon, University of Liverpool

Joanne Lewis, King’s College London (KCL)

Samantha Mills, Neuroradiologist, Walton Centre

Paul Sanghera, Consultant Clinical Oncologist, University Hospitals Birmingham NHS Foundation Trust

Gillian Whitfield, Consultant in Clinical Oncology, Christie NHS Foundation Trust

Rasheed Zakaria, Walton Centre

The Supportive & Palliative Care Subgroup, chaired by Dr Robin Grant, develops research into side effects caused by treatment of brain tumours, and psychological and social problems related to a disease or its treatment.


Robin Grant, Western General Hospital (subgroup chair)

Ann Arber, University of Surrey

Florien Boele, University Academic Fellow, University of Leeds

Anthony Byrne, Consultant in Palliative Medicine, Cardiff University

Helen Bulbeck, NCRI Consumer Forum Member, Brainstrust

Willie Hamilton, Professor of primary care diagnostics, University of Exeter

Cressida Lorimer, Clinical Research Fellow in Neuro-Oncology, Brighton and Sussex University Hospitals NHS Trust

Rose Marshall, Guy’s and St Thomas’ NHS Foundation Trust

Catherine McBain, Consultant Clinical Oncologist, Christie NHS Foundation Trust

Kathy Oliver

Diane Playford, University College London (UCL)